首頁 > 市場調查報告書 > 醫療設備

導管

生物可吸收支架市場規模、佔有率和成長分析（按材料類型、應用、最終用戶和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1897595

生物可吸收支架市場規模、佔有率和成長分析（按材料類型、應用、最終用戶和地區分類）—2026-2033年產業預測

Bioresorbable Scaffolds Market Size, Share, and Growth Analysis, By Material Type (Polymer-based Scaffolds, Metallic Scaffolds), By Application (Coronary Artery Disease, Peripheral Artery Disease), By End-user, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，生物可吸收支架市場規模將達到 20.4 億美元，到 2025 年將達到 24.4 億美元，到 2033 年將達到 101.4 億美元，在預測期（2026-2033 年）內複合年成長率為 19.5%。

由於醫療技術的進步和心血管疾病盛行率的迅速上升，生物可吸收支架市場正經歷強勁成長。這些臨時植入會隨著時間的推移而逐漸溶解，從而促進血管的自然癒合。該市場按材料類型、應用、最終用戶和地區進行細分。聚合物基支架因其良好的生物相容性和可吸收性主導主導地位，其中心血管疾病的需求量最大。醫院、門診手術中心和專科診所是主要的最終用戶，這主要得益於接受介入性心臟病手術的住院患者數量的增加。北美憑藉其先進的醫療基礎設施佔據了較大的市場佔有率，其次是歐洲的研究舉措和亞太地區不斷成長的投資。儘管面臨高成本等挑戰，但持續的研發預計將支撐未來的市場成長。

生物可吸收支架市場促進因素

心血管疾病（包括冠狀動脈疾病和周邊動脈疾病）發生率的不斷上升是生物可吸收支架市場成長的主要驅動力。隨著這些健康問題的日益普遍，迫切需要能夠恢復正常血液循環的有效治療方法。這種不斷成長的需求正在推動創新醫療解決方案的研發，尤其是生物可吸收支架，它們在治療這些複雜的心血管疾病方面展現出良好的前景。不斷尋求針對這些常見疾病的更有效治療方法是推動生物可吸收支架市場發展的根本因素。

生物可吸收支架市場受到抑制

由於缺乏長期臨床證據，生物可吸收支架市場面臨許多挑戰。亟需進行全面的評估，比較生物可吸收支架植入與傳統支架的性能。若缺乏這項關鍵評估，則難以最終確定生物可吸收支架的有效性和安全性。缺乏可靠的臨床數據阻礙了市場成長，因為除非有明確證據表明其優於傳統方案，否則醫療機構可能不願意採用這些創新解決方案。因此，解決這個問題對於生物可吸收支架市場的未來發展至關重要。

生物可吸收支架市場趨勢

生物可吸收支架的需求正呈現顯著上升趨勢，這主要得益於日益成長的老齡人口對先進醫療解決方案的需求。隨著老年人更容易罹患心血管疾病，對有效且創新治療方法的需求也日益增加。生物可吸收支架因其在治療後可被人體自然吸收的特性而備受青睞，可望減少與永久性裝置相關的長期併發症。這種向微創、臨時性解決方案的轉變代表了醫療保健領域的一個更廣泛趨勢，體現了醫療服務提供者在滿足老年患者特殊需求的同時，不斷努力改善患者療效的決心。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Abbott Laboratories（USA）
Boston Scientific Corporation（USA）
Medtronic plc（Ireland）
Terumo Corporation（Japan）
Biotronik SE & Co. KG（Germany）
REVA Medical, Inc.（USA）
Elixir Medical Corporation（USA）
Amaranth Medical, Inc.（USA）
Arterial Remodeling Technologies（France）
Meril Life Sciences Pvt. Ltd.（India）
Kyoto Medical Planning Co., Ltd.（Japan）
Lepu Medical Technology（Beijing）Co., Ltd.（China）
S3V Vascular Technologies（India）
Zorion Medical（USA）
ICON Interventional Systems（USA）
Xenogenics Corporation（USA）
Arterius Limited（UK）
SMT（Sahajanand Medical Technologies）（India）
B. Braun Melsungen AG（Germany）
Cardionovum GmbH（Germany）

結論與建議

簡介目錄

Product Code: SQMIG35A2472

Bioresorbable Scaffolds Market size was valued at USD 2.04 Billion in 2024 and is poised to grow from USD 2.44 Billion in 2025 to USD 10.14 Billion by 2033, growing at a CAGR of 19.5% during the forecast period (2026-2033).

The bioresorbable scaffolds market is experiencing robust growth driven by advancements in medical technology and a surge in cardiovascular disease prevalence. These temporary implants promote natural vessel healing by gradually dissolving over time, with the market segmented into material type, application, end-user, and region. Polymer-based scaffolds lead due to their biocompatibility and resorption characteristics, while applications are primarily centered on cardiovascular diseases, which dominate demand. Hospitals, ambulatory surgical centers, and specialized clinics serve as key end-users, fueled by increasing cardiac intervention admissions. North America holds a significant share, supported by advanced healthcare infrastructure, followed by Europe's research initiatives and the Asia-Pacific region's growing investments. Although challenges like high costs exist, ongoing research is expected to bolster market growth in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioresorbable Scaffolds market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioresorbable Scaffolds Market Segments Analysis

Global Bioresorbable Scaffolds Market is segmented by Material Type, Application, End-user and region. Based on Material Type, the market is segmented into Polymer-based Scaffolds and Metallic Scaffolds. Based on Application, the market is segmented into Coronary Artery Disease and Peripheral Artery Disease. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Cardiac Catheterization Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioresorbable Scaffolds Market

The increasing incidence of cardiovascular conditions, including coronary artery disease and peripheral artery disease, significantly fuels the growth of the bioresorbable scaffolds market. As these health issues become more common, there is an urgent need for effective treatment options that can restore proper blood flow. This rising demand encourages the development of innovative medical solutions, particularly bioresorbable scaffolds, which offer promising results in managing these complex cardiovascular conditions. The continuous search for improved therapeutic approaches in the face of these prevalent disorders is thus a fundamental factor driving the bioresorbable scaffolds market forward.

Restraints in the Bioresorbable Scaffolds Market

The bioresorbable scaffolds market encounters significant obstacles due to a scarcity of long-term clinical evidence. There is a pressing need for comprehensive assessments comparing the performance of bioresorbable scaffold implants with that of conventional stents. Without this crucial evaluation, it remains difficult to definitively establish the efficacy and safety of bioresorbable scaffolds. This lack of robust clinical data hinders the market's growth, as healthcare providers may be hesitant to adopt these innovative solutions without clear evidence of their advantages over traditional options. Consequently, addressing this issue is vital for the future advancement of the bioresorbable scaffolds market.

Market Trends of the Bioresorbable Scaffolds Market

The demand for bioresorbable scaffolds is witnessing a significant upward trend, largely propelled by the rise of the geriatric population, which necessitates enhanced healthcare solutions. As older individuals become more prone to cardiovascular diseases, the requirement for effective and innovative treatment options intensifies. Bioresorbable scaffolds, known for their ability to dissolve within the body post-treatment, are increasingly favored for their potential to reduce long-term complications associated with permanent devices. This shift towards less invasive, temporary solutions reflects a broader movement in healthcare, as providers aim to meet the unique needs of aging patients while continually improving patient outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis

Global Bioresorbable Scaffolds Market Size by Material Type & CAGR (2026-2033)

Market Overview
Polymer-based Scaffolds
Metallic Scaffolds

Global Bioresorbable Scaffolds Market Size by Application & CAGR (2026-2033)

Market Overview
Coronary Artery Disease
Peripheral Artery Disease

Global Bioresorbable Scaffolds Market Size by End-user & CAGR (2026-2033)

Market Overview
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories

Global Bioresorbable Scaffolds Market Size & CAGR (2026-2033)

North America (Material Type, Application, End-user)
- US
- Canada
Europe (Material Type, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Material Type, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Material Type, Application, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Material Type, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
REVA Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elixir Medical Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amaranth Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arterial Remodeling Technologies (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kyoto Medical Planning Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology (Beijing) Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
S3V Vascular Technologies (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zorion Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON Interventional Systems (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Xenogenics Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arterius Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SMT (Sahajanand Medical Technologies) (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardionovum GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments